Pharmacists United for Truth and Transparency is a growing coalition of independent pharmacists and pharmacy owners dedicated to exposing widespread abuse and manipulation by pharmacy benefit managers (PBMs).
Pharmacy Bill Has Many Benefits – Albany Times Union September 26, 2011
The state Senate and Assembly overwhelmingly passed the anti-mandatory mail order prescription bill (5502-B) for good reason: It helps restore the patient’s choice of pharmacy and supports local jobs and economies.
Independent Pharmacies Struggle – Oregon Business August 2011
Bob Coulter, an independent pharmacist in La Grande, is bucking industry trends. Between 2009 and May 2011, the number of independently owned pharmacies in Oregon dropped from 161 to 97.
Pressure Grows to Unwind CVS Merger – New York Times April 14, 2011
CVS Caremark is coming under increasing pressure from consumer groups and shareholders to split up, at the same time that federal and state regulators are looking into accusations of anticompetitive behavior by the merged company. The four-year-old merger of the drugstore chain and the pharmacy benefit manager is the subject of an investigation by the Federal Trade Commission and a multistate inquiry by the attorneys general of 24 states, according to earlier disclosures by CVS Caremark.
Pharmacists Fight the Rise of Mail Order – New York Times March 3, 2011 A fierce battle is being waged between retail pharmacists and mail-order companies over where people should be able to fill their long-termprescriptions. Community pharmacists in New York are lobbying state lawmakers to pass legislation that would prevent health plans from requiring patients taking medications for chronic ailments to fill their prescriptions through the mail.
Bill Seeks Transparency in Employee’s Health Program – Washington Post February 24, 2010
With federal employees spending more than $10 billion a year on prescriptions, they might expect that their buying power would result in significant savings. But apparently that is not the case — or, if it is, no one really knows, because the system that the Federal Employees Health Benefits Program uses to buy drugs is clouded with unknowns.